CLEVELAND — Cindy Elford was the first patient at University Hospitals Cleveland Medical Center to have her leg saved by the LimFlow device. We met just after the procedure. Years later, she's still ...

Daniel Rose was recently appointed CEO of LimFlow, a Paris-based company that’s developing a therapy to restore lower leg blood flow for people with virtually no circulation. Most of these patients ...

PARIS, July 28, 2021 /PRNewswire/ -- Today, LimFlow SA, the pioneer in developing minimally-invasive technology to treat chronic limb-threatening ischemia (CLTI), announced remarkable health economic ...

IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ...

PARIS--(BUSINESS WIRE)--LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery ...

Inari Medical has agreed to acquire LimFlow, maker of a device to treat patients with chronic limb-threatening loss of blood flow, for $250 million in cash plus potential milestone payments, bringing ...

PARIS--(BUSINESS WIRE)--LimFlow SA, developer of endovascular technology transforming the treatment of critical limb ischemia (CLI), has named Daniel Rose as chief executive officer (CEO), effective ...

Inari Medical has signed on to a $415 million deal to acquire LimFlow, just weeks after the company received an FDA approval for its minimally invasive approach to re-establish oxygenated blood flow ...

PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)-- LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of ...

The first ever LimFlow procedure in the Western United States, was performed at Heart Hospital of New Mexico at Lovelace Medical Center by New Mexico Heart Institute vascular surgeons, Steven Henao ...

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and ...